Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2974 studies found for:    Pulmonary Disease, Chronic Obstructive
Show Display Options
Download search resultsDownload the search results for:
Pulmonary Disease, Chronic Obstructive (2974 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
2 Completed
Has Results
A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Placebo;   Biological: Benralizumab 100 mg
3 Unknown  Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Patient education and disease management
4 Terminated Portable Monitoring Device for the Diagnosis of Sleep Apnea in Patients With Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Obstructive Sleep Apnea Syndrome
Intervention: Device: Polysomnography
5 Completed A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: CNTO 6785;   Drug: Placebo
6 Completed Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® inhalets
7 Completed Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® inhalets
8 Completed Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® - inhalets
9 Completed Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® Inhalation Solution
10 Completed Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® - inhalets
11 Completed Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Ventilat® - metered dose inhaler
12 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol xinafoate combination;   Drug: Other maintenance Treatments (OMT)
13 Completed Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Subjects with COPD;   Other: Subjects without COPD
14 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol xinafoate;   Drug: Anticholinergics
15 Terminated
Has Results
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: UK-432,097;   Drug: Placebo
16 Completed
Has Results
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS™ 250/50mcg;   Other: Placebo
17 Completed Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Atrovent®;   Drug: Ventilat®
18 Completed
Has Results
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone propionate/salmeterol combination product;   Drug: Salmeterol;   Drug: Placebo
19 Completed A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
20 Completed
Has Results
A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GW685698/GW642444

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.